Logo-bma
PDFPDF
XMLXML
Cited By:
Opinion
Fatima Elmusa ORCID, Mohammadreza Dastouri* ORCID
Biomed adv. 2026;3(2): 44-46. doi: 10.34172/bma.68
PDFPDF
XMLXML
Cited By:
Review Article Cancer Biology
Sanaz Aghajani ORCID, Seyed Ali Maboudi, Nasim Vousooghi, Iman Seyhoun, Masoumeh Majidizolbin, Alireza Namazi Shabestari, Arvin Namazi Shabestari, Javad Verdi* ORCID
Biomed adv. 2026;3(2): 47-57. doi: 10.34172/bma.53
PDFPDF
XMLXML
Cited By:
Review Article
Hossein Soltaninejad* ORCID, Mohadeseh Khoshandam, Elham Karimi, Reza Sheikhakbari, Mojdeh Hosseinpoor Kashani
Biomed adv. 2026;3(2): 58-63. doi: 10.34172/bma.54
PDFPDF
XMLXML
Cited By:
Review Article Cancer Biology
Abolfazl Jalilvand ORCID, Mohammadhossein Kouhpaeenejad, Leila Faeli, Nesa Rashidi* ORCID
Biomed adv. 2026;3(2): 64-71. doi: 10.34172/bma.63
PDFPDF
XMLXML
Cited By:
Review Article
Maryam Sadri ORCID, Sama Sadri, Hossein Khorramdelazad, Mohammad Reza Bolouri, Ahmad Vosughi Motlagh* ORCID
Biomed adv. 2026;3(2): 72-82. doi: 10.34172/bma.61
PDFPDF
XMLXML
Cited By:
Case Report
Orkun Canbolat* ORCID, Şeyma Yeşil ORCID, Yelda Saltan Özateş ORCID, Ufuk Yıldız ORCID, Duygu Inan ORCID, Alev Kılıcgedik ORCID
Biomed adv. 2026;3(2): 83-86. doi: 10.34172/bma.65

Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.